Skip to main content
Top
Published in: BMC Public Health 1/2019

Open Access 01-12-2019 | Public Health | Research article

Estimating the public health impact of a national guideline on cervical cancer screening: an audit study of a program in Campinas, Brazil

Authors: Diama Bhadra Vale, Talita Lourenço Menin, Joana Froes Bragança, Julio Cesar Teixeira, Lucas Almeida Cavalcante, Luiz Carlos Zeferino

Published in: BMC Public Health | Issue 1/2019

Login to get access

Abstract

Background

A Brazilian guideline on cervical cancer screening was released in 2011. The objective was to verify changes in screening indicators around this period.

Methods

An audit study which sample was all screening tests performed by the public health system of Campinas city from 2010 to 2016. Variables were absolute tests numbers, excess tests, intervals and results, by age. For trend analysis was used Cochran-Armitage × 2 and linear regression.

Results

Were carried out 62,925 tests in 2010 and 43,523 tests in 2016, a tendency at a reduction (P = 0.001). Excess tests were higher than 50% over the years, with a tendency at a reduction (P < 0.001). Tests performed on women under 25 ranged from 20.2 to 15.4% in the period (P < 0.001), while in the 25–64 years age-group, it ranged from 75.1 to 80.2% (P < 0.001). In 2010 the most frequent interval was annual (47.5%) and in 2016 biennial (34.7%). There was a tendency at a reduction in the proportion of tests performed at the first time and those with an annual interval (P < 0.001), and also a tendency at an increase in tests with intervals equal to or greater than biannual (P < 0.001). We observed a tendency at a reduction in LSIL and HSIL-CIN2 results (P = 0.04 and P = 0.001, respectively), and a tendency at an increase in HSIL-CIN3 result (P = 0.02).

Conclusion

The proportion of cervical cancer screening tests performed out of the recommendation showed a significant reduction in the period. This indicates a tendency to align cervical cancer screening in Campinas with the standards recommended.
Literature
3.
go back to reference Vale DB, Sauvaget C, Muwonge R, Ferlay J, Zeferino LC, Murillo R, et al. Disparities in time trends of cervical cancer mortality rates in Brazil. Cancer Causes Control. 2016;27:889–96.CrossRef Vale DB, Sauvaget C, Muwonge R, Ferlay J, Zeferino LC, Murillo R, et al. Disparities in time trends of cervical cancer mortality rates in Brazil. Cancer Causes Control. 2016;27:889–96.CrossRef
4.
go back to reference Instituto Nacional de Câncer. Diretrizes Brasileiras para o Rastreamento do Câncer do Colo do Útero 2016 - Second Edition. 2016. Instituto Nacional de Câncer. Diretrizes Brasileiras para o Rastreamento do Câncer do Colo do Útero 2016 - Second Edition. 2016.
5.
go back to reference Madlensky L, Goel V, Polzer J, Ashbury FD. Assessing the evidence for systematic cancer screening programmes. Eur J Cancer. 2003;39:1648–53.CrossRef Madlensky L, Goel V, Polzer J, Ashbury FD. Assessing the evidence for systematic cancer screening programmes. Eur J Cancer. 2003;39:1648–53.CrossRef
6.
go back to reference Vale DB, Morais SS, Pimenta AL, Zeferino LC. Assessment of the cervical cancer screening in the Family Health Strategy in Amparo, São Paulo State, Brazil. Cadernos De Saude Publica. 2010;26:383–90.CrossRef Vale DB, Morais SS, Pimenta AL, Zeferino LC. Assessment of the cervical cancer screening in the Family Health Strategy in Amparo, São Paulo State, Brazil. Cadernos De Saude Publica. 2010;26:383–90.CrossRef
8.
go back to reference Instituto Nacional de Câncer (Brazil). Brazilian nomenclature for cervical cytology reports and guidelines. Rev Bras Cancerologia. 2006;52:213–36. Instituto Nacional de Câncer (Brazil). Brazilian nomenclature for cervical cytology reports and guidelines. Rev Bras Cancerologia. 2006;52:213–36.
9.
go back to reference Instituto Nacional de Câncer (Brazil). Diretrizes Brasileiras para o Rastreamento do Câncer do Colo do Utero. Rio de Janeiro: INCA; 2011. Instituto Nacional de Câncer (Brazil). Diretrizes Brasileiras para o Rastreamento do Câncer do Colo do Utero. Rio de Janeiro: INCA; 2011.
10.
go back to reference Ministério da Saúde, Brasil. Portaria no 2.012, August 23, 2011. 2011. Ministério da Saúde, Brasil. Portaria no 2.012, August 23, 2011. 2011.
13.
go back to reference Van Ballegooijen M, Van den Akker-van Marle E, Patnick J, Lynge E, Arbyn M, Anttila A, et al. Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness. Eur J Cancer. 2000;36:2177–88.CrossRef Van Ballegooijen M, Van den Akker-van Marle E, Patnick J, Lynge E, Arbyn M, Anttila A, et al. Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness. Eur J Cancer. 2000;36:2177–88.CrossRef
14.
go back to reference Volume J. Screening for squamous cervical cancer: Duration of low risk after negative results of cervical cytology and its implication for screening policies: Iarc Working Group on Evaluation of Cervical Cancer Screening Programmes. Br Med J. 1986;293:659–64.CrossRef Volume J. Screening for squamous cervical cancer: Duration of low risk after negative results of cervical cytology and its implication for screening policies: Iarc Working Group on Evaluation of Cervical Cancer Screening Programmes. Br Med J. 1986;293:659–64.CrossRef
15.
go back to reference Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11; 2013. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11; 2013.
16.
go back to reference Sasieni P, Castanon A, Cuzick J, Snow J. Effectiveness of cervical screening with age: Population-based case-control study of prospectively recorded data. BMJ. 2009;339:328.CrossRef Sasieni P, Castanon A, Cuzick J, Snow J. Effectiveness of cervical screening with age: Population-based case-control study of prospectively recorded data. BMJ. 2009;339:328.CrossRef
18.
go back to reference Lynge E1, Clausen LB, Guignard R, Poll P. What happens when organization of cervical cancer screening is delayed or stopped? 2006;13(1):41–6. Lynge E1, Clausen LB, Guignard R, Poll P. What happens when organization of cervical cancer screening is delayed or stopped? 2006;13(1):41–6.
19.
go back to reference Kyrgiou M, Athanasiou A, Paraskevaidi M, Mitra A, Kalliala I, Martin-Hirsch P, et al. Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis. BMJ. 2016;354:i3633.CrossRef Kyrgiou M, Athanasiou A, Paraskevaidi M, Mitra A, Kalliala I, Martin-Hirsch P, et al. Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis. BMJ. 2016;354:i3633.CrossRef
20.
go back to reference Lee MH, Finlayson SJ, Gukova K, Hanley G, Miller D, Sadownik LA. Outcomes of conservative Management of High Grade Squamous Intraepithelial Lesions in young women. J Low Genit Tract Dis. 2018;22:212–8.CrossRef Lee MH, Finlayson SJ, Gukova K, Hanley G, Miller D, Sadownik LA. Outcomes of conservative Management of High Grade Squamous Intraepithelial Lesions in young women. J Low Genit Tract Dis. 2018;22:212–8.CrossRef
21.
go back to reference Tainio K, Athanasiou A, Tikkinen KAO, Aaltonen R, Cárdenas J, Hernándes, et al. Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis. BMJ. 2018;360:k499. https://doi.org/10.1136/bmj.k499. Tainio K, Athanasiou A, Tikkinen KAO, Aaltonen R, Cárdenas J, Hernándes, et al. Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis. BMJ. 2018;360:k499. https://​doi.​org/​10.​1136/​bmj.​k499.
22.
go back to reference Basu P, Ponti A, Anttila A, Ronco G, Senore C, Vale DB, et al. Status of implementation and organization of cancer screening in the European Union member states—summary results from the second European screening report. Int J Cancer. 2018;142:44–56.CrossRef Basu P, Ponti A, Anttila A, Ronco G, Senore C, Vale DB, et al. Status of implementation and organization of cancer screening in the European Union member states—summary results from the second European screening report. Int J Cancer. 2018;142:44–56.CrossRef
Metadata
Title
Estimating the public health impact of a national guideline on cervical cancer screening: an audit study of a program in Campinas, Brazil
Authors
Diama Bhadra Vale
Talita Lourenço Menin
Joana Froes Bragança
Julio Cesar Teixeira
Lucas Almeida Cavalcante
Luiz Carlos Zeferino
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2019
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-019-7846-2

Other articles of this Issue 1/2019

BMC Public Health 1/2019 Go to the issue